General Info
Huahai US creates, purchases, licenses, registers, sells, and distributes generic medications that are prescribed by doctors.
Location: Somerset
Country:
Industries:
Investment Regions:
Investment Stages: late-stage, pre-seed, seed, series-a
Website: http://www.huahaipharm.com/
corporate-vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Crunchbase shows a single investment by Huahai US in Apeximmune Therapeutics (Series A). The funding round date on Crunchbase for Apeximmune Series A is in 2022 (more than 12 months ago). Therefore the investor’s last known investment occurred over 12 months ago, which corresponds to the selected tag. The startup invested: Apeximmune Therapeutics.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Huahai US
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI